E-LIB Suche - Ergebnisse für: Justin Carrico

1

Updated Public Health Impact and Cost Effectiveness of Reco..:

George, Sydney ; Carrico, Justin ; Hicks, Katherine A....
PharmacoEconomics - Open. 8 (2024) 3 - p. 481-492 , 2024

Link: https://doi.org/10.1007/..

2

Public health impact and return on investment of the pediat..:

Mellott, Claire E. ; Jaworski, Rafal ; Carrico, Justin...
Expert Review of Vaccines. 22 (2023) 1 - p. 1114-1125 , 2023

Link: https://doi.org/10.1080/..

3

Estimating the cost of university-based outbreaks of serogr..:

Hicks, Katherine A. ; Ghaswalla, Parinaz ; Carrico, Justin...
Journal of American College Health. , 2023

Link: https://doi.org/10.1080/..

4

Cost-Effectiveness of Recombinant Zoster Vaccine for the Pr..:

Salem, Ahmed ; La, Elizabeth M. ; Curran, Desmond...
PharmacoEconomics - Open. 7 (2023) 6 - p. 975-985 , 2023

Link: https://doi.org/10.1007/..

5

Public health impact and return on investment of Belgium's ..:

Carrico, Justin ; Mellott, Claire E. ; Talbird, Sandra E....
Frontiers in Public Health. 11 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

The Annual Economic Burden of Respiratory Syncytial Virus i..:

Carrico, Justin ; Hicks, Katherine A ; Wilson, Eleanor..
The Journal of Infectious Diseases. , 2023

Link: https://doi.org/10.1093/..

7

903. Prevalence of Underlying Conditions Associated With Hi..:

Ghaswalla, Parinaz ; Hitchens, Abby ; Candrilli, Sean D...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

8

Public health impact of recombinant zoster vaccine for prev..:

Curran, Desmond ; Patterson, Brandon J. ; Carrico, Justin...
Human Vaccines & Immunotherapeutics. 19 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

9

Burden of opioid use for pain management among adult herpes..:

Poirrier, Jean-Etienne ; DeMartino, Jessica K. ; Nagar, Saurabh...
Human Vaccines & Immunotherapeutics. 18 (2022) 5 - p. , 2022

Link: https://doi.org/10.1080/..

10

Cost-benefit analysis of vaccination against four preventab..:

Carrico, Justin ; Talbird, Sandra E. ; La, Elizabeth M....
Vaccine. 39 (2021) 36 - p. 5187-5197 , 2021

Link: https://doi.org/10.1016/..

11

Estimated Public Health Impact of the Recombinant Zoster Va..:

Patterson, Brandon J. ; Buck, Philip O. ; Curran, Desmond...
Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 5 (2021) 3 - p. 596-604 , 2021

Link: https://doi.org/10.1016/..

12

20. Cost-Effectiveness of Recombinant Zoster Vaccine for Va..:

Curran, Desmond ; Salem, Ahmed ; Lorenc, Stéphane...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S134-S134 , 2021

Link: https://doi.org/10.1093/..

13

The Budget Impact of Introducing Tildrakizumab to a United ..:

Carrico, Justin ; Zhao, Yang ; Jia, Xiaoying...
PharmacoEconomics - Open. 4 (2020) 4 - p. 669-677 , 2020

Link: https://doi.org/10.1007/..

14

Cost-effectiveness of tildrakizumab for the treatment of mo..:

Jia, Xiaoying ; Zhao, Yang ; Carrico, Justin...
Journal of Dermatological Treatment. 33 (2020) 2 - p. 740-748 , 2020

Link: https://doi.org/10.1080/..

15

Impact of population aging on the burden of vaccine-prevent..:

Talbird, Sandra E ; La, Elizabeth M ; Carrico, Justin...
Human Vaccines & Immunotherapeutics. 17 (2020) 2 - p. 332-343 , 2020

Link: https://doi.org/10.1080/..